Top Markets
Coin of the day
Lysogene S.A. Lysogene S.A.

Lysogene S.A.

LYS
Rangering i aksjer #36618
Lysogene S.A. is a biopharmaceutical firm specializing in gene therapy,... Lysogene S.A. is a biopharmaceutical firm specializing in gene therapy, dedicated to discovering and advancing treatments for children affected by severe neurodegenerative lysosomal storage disorders. Its development pipeline includes LYS-SAF302, which is currently undergoing Phase II/III clinical trials for mucopolysaccharidosis type IIIA (MPS IIIA). Another promising candidate, LYS-GM101, is in Phase I/II development, targeting GM1 gangliosidosis. The company has also forged a research alliance with the Weizmann Institute of Science to pioneer novel adeno-associated virus (AAV) gene therapy approaches for conditions such as neuronopathic Gaucher disease, Parkinson's disease, and other related illnesses. Lysogene S.A. was established in 2009 and is headquartered in Neuilly-sur-Seine, France.
Aksjekurs
$0.30221445
Sist synkronisert: 2023-05-22
Markedsverdi
$2.49M
Endring (1 dag)
-0.10%
Endring (1 år)
0.00%
Land
FR
Handel Lysogene S.A. (LYS)

Kategori

Historikk for aksjesplitt for Lysogene S.A. (LYS)
Aksjen Lysogene S.A. (symbol: LYS) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 15, 2026.
Én LYS-aksje kjøpt før Aug 15, 2026 tilsvarer i dag 0 LYS-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE